Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T G Heffner

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Journal of Medicinal Chemistry|December 22, 1995
Identification, characterization and pharmacological profile of three metabolites of (R)-(+)-1,2,3,6-tetrahydro-4-phenyl-1-[(3-phenylcyclohexen-1- yl)methyl]pyridine (CI-1007), a dopamine autoreceptor agonist and potential antipsychotic agentJ L Wright, D M Downing, M R Feng, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Pharmacologic/pharmacokinetic evaluation of emesis induced by analogs of RSU 1069 and its control by antiemetic agentsJ S Sebolt-Leopold, P W Vincent, K A Beningo, et al.
Journal of Medicinal Chemistry|October 11, 1996
Affinity for dopamine D2, D3, and D4 receptors of 2-aminotetralins. Relevance of D2 agonist binding for determination of receptor subtype selectivityL A van Vliet, P G Tepper, D Dijkstra, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Pyrazolo[1,5-a]pyrimidine CRF-1 receptor antagonistsD J Wustrow, T Capiris, R Rubin, et al.
Journal of Medicinal Chemistry|October 1, 1987
1,3-Dialkyl-4-(iminoarylmethyl)-1H-pyrazol-5-ols. A series of novel potential antipsychotic agentsL D Wise, D E Butler, H A DeWald, et al.
Journal of Medicinal Chemistry|March 1, 1986
Ribose-modified adenosine analogues as adenosine receptor agonistsM D Taylor, W H Moos, H W Hamilton, et al.
International Journal of Peptide and Protein Research|September 1, 1994
Structure-activity and conformational studies of a series of modified C-terminal hexapeptide neurotensin analoguesD L Heyl, A M Sefler, J X He, et al.
Journal of Medicinal Chemistry|October 14, 1994
The discovery and structure-activity relationships of 1,2,3,6-tetrahydro-4-phenyl-1-[(arylcyclohexenyl)alkyl]pyridines. Dopamine autoreceptor agonists and potential antipsychotic agentsJ L Wright, B W Caprathe, D M Downing, et al.
Pharmacology, Biochemistry, and Behavior|February 26, 1998
Pharmacological characterization of PD 152255, a novel dimeric benzimidazole dopamine D3 antagonistA E Corbin, T A Pugsley, H C Akunne, et al.
Pharmaceutical Research|March 1, 1997
Pharmacokinetics and pharmacodynamics of an investigational antipsychotic agent, CI-1007, in rats and monkeysM R Feng, A E Corbin, Y Wang, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Journal of Medicinal Chemistry|December 22, 1995
Identification, characterization and pharmacological profile of three metabolites of (R)-(+)-1,2,3,6-tetrahydro-4-phenyl-1-[(3-phenylcyclohexen-1- yl)methyl]pyridine (CI-1007), a dopamine autoreceptor agonist and potential antipsychotic agentJ L Wright, D M Downing, M R Feng, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1992
Pharmacologic/pharmacokinetic evaluation of emesis induced by analogs of RSU 1069 and its control by antiemetic agentsJ S Sebolt-Leopold, P W Vincent, K A Beningo, et al.
Journal of Medicinal Chemistry|October 11, 1996
Affinity for dopamine D2, D3, and D4 receptors of 2-aminotetralins. Relevance of D2 agonist binding for determination of receptor subtype selectivityL A van Vliet, P G Tepper, D Dijkstra, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Pyrazolo[1,5-a]pyrimidine CRF-1 receptor antagonistsD J Wustrow, T Capiris, R Rubin, et al.
Journal of Medicinal Chemistry|October 1, 1987
1,3-Dialkyl-4-(iminoarylmethyl)-1H-pyrazol-5-ols. A series of novel potential antipsychotic agentsL D Wise, D E Butler, H A DeWald, et al.
Journal of Medicinal Chemistry|March 1, 1986
Ribose-modified adenosine analogues as adenosine receptor agonistsM D Taylor, W H Moos, H W Hamilton, et al.
International Journal of Peptide and Protein Research|September 1, 1994
Structure-activity and conformational studies of a series of modified C-terminal hexapeptide neurotensin analoguesD L Heyl, A M Sefler, J X He, et al.
Journal of Medicinal Chemistry|October 14, 1994
The discovery and structure-activity relationships of 1,2,3,6-tetrahydro-4-phenyl-1-[(arylcyclohexenyl)alkyl]pyridines. Dopamine autoreceptor agonists and potential antipsychotic agentsJ L Wright, B W Caprathe, D M Downing, et al.
Pharmacology, Biochemistry, and Behavior|February 26, 1998
Pharmacological characterization of PD 152255, a novel dimeric benzimidazole dopamine D3 antagonistA E Corbin, T A Pugsley, H C Akunne, et al.
Pharmaceutical Research|March 1, 1997
Pharmacokinetics and pharmacodynamics of an investigational antipsychotic agent, CI-1007, in rats and monkeysM R Feng, A E Corbin, Y Wang, et al.
Pageof 7